Idenix Pharmaceuticals Inc. (IDIX)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 0 |
| Ownership rank: | -- |
| % of all portfolios: | 0% |
| History | Portfolio Manager | Activity ▲ | Share change | % change to portfolio | |
| Q3 2014 | |||||
| ≡ | Prem Watsa - Fairfax Financial Holdings | Sell 100.00% | 50,400 | 0.08 | |
| ≡ | Seth Klarman - Baupost Group | Sell 100.00% | 53,331,109 | 21.00 | |
| Q2 2014 | |||||
| ≡ | Prem Watsa - Fairfax Financial Holdings | Buy | 50,400 | 0.08 | |
| Q1 2014 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 44.49% | 16,420,241 | 2.30 | |
| Q4 2013 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 24.42% | 7,245,175 | 1.26 | |
| Q3 2013 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 10.83% | 2,898,693 | 0.44 | |
| Q2 2013 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 2.78% | 725,000 | 0.07 | |
| Q1 2013 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 25.78% | 5,337,300 | 0.64 | |
| Q4 2012 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 72.54% | 8,704,700 | 1.41 | |
| Q3 2012 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 20.00% | 2,000,000 | 0.28 | |
| Q2 2012 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 21.23% | 1,751,000 | 0.48 | |
| Q1 2012 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 45.61% | 2,584,000 | 0.87 | |
| Q4 2011 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 126.60% | 3,165,000 | 0.72 | |
| Q3 2011 | |||||
| ≡ | Seth Klarman - Baupost Group | Add 99.09% | 1,244,300 | 0.21 | |
| Q2 2011 | |||||
| ≡ | Seth Klarman - Baupost Group | Buy | 1,255,700 | 0.27 | |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.